sample_name,protocol,organism,read_type,data_source,srr,srx,sample_title,sample_geo_accession,sample_status,sample_submission_date,sample_last_update_date,sample_type,sample_channel_count,sample_source_name_ch1,sample_organism_ch1,sample_taxid_ch1,sample_characteristics_ch1,sample_growth_protocol_ch1,sample_molecule_ch1,sample_label_ch1,sample_source_name_ch2,sample_organism_ch2,sample_taxid_ch2,sample_characteristics_ch2,sample_growth_protocol_ch2,sample_molecule_ch2,sample_label_ch2,sample_description,sample_platform_id,sample_contact_name,sample_contact_email,sample_contact_phone,sample_contact_institute,sample_contact_address,sample_contact_city,sample_contact_state,sample_contact_zip_postal_code,sample_contact_country,sample_supplementary_file,sample_series_id,sample_data_row_count,id_ref,value,big_key,identifier,gender,age,mitotic_index,ulceration_status,histotype,anatomical_site_of_primary_tumor,stage,recurrence,site_of_1st_recurrence,brain_as_isolated_1st_site_of_recurrence,b-met,last_status,cause_of_death
primary_melanoma_001,,,,,,,Primary Melanoma_001,GSM1526020,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 10(time to 1st recurrence (days): 617(time to 1st recurrence (months): 20(time to b-met (days): 1088(follow-up time (days): 1094(follow-up time (months): 35,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526020/suppl/GSM1526020_0_Exiqon_14257951_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526020/suppl/GSM1526020_1_Exiqon_14257951_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526020,001,F,81,Moderate,Present,Nodular,Extremity,IIIB,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_002,,,,,,,Primary Melanoma_002,GSM1526021,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.7(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3860(follow-up time (months): 126,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526021/suppl/GSM1526021_0_Exiqon_14257832_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526021/suppl/GSM1526021_1_Exiqon_14257832_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526021,002,M,65,Many,Absent,Superficial Spreading,Axial,IIIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_003,,,,,,,Primary Melanoma_003,GSM1526022,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.6(time to 1st recurrence (days): 234(time to 1st recurrence (months): 8(time to b-met (days): NA(follow-up time (days): 525(follow-up time (months): 17,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526022/suppl/GSM1526022_0_Exiqon_14257861_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526022/suppl/GSM1526022_1_Exiqon_14257861_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526022,003,M,87,Many,Present,Nodular,Extremity,IIB,Y,RLN,N,N,"Died, No Melanoma",Burns
primary_melanoma_004,,,,,,,Primary Melanoma_004,GSM1526023,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.06(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3092(follow-up time (months): 101,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526023/suppl/GSM1526023_0_Exiqon_14257953_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526023/suppl/GSM1526023_1_Exiqon_14257953_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526023,004,M,35,Moderate,Absent,Superficial Spreading,Extremity,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_005,,,,,,,Primary Melanoma_005,GSM1526024,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 10.75(time to 1st recurrence (days): 258(time to 1st recurrence (months): 9(time to b-met (days): NA(follow-up time (days): 896(follow-up time (months): 29,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526024/suppl/GSM1526024_0_Exiqon_14257856_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526024/suppl/GSM1526024_1_Exiqon_14257856_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526024,005,M,76,Moderate,Absent,Nodular,Axial,IIB,Y,DS,N,N,"Died, No Melanoma",Prostate Cancer
primary_melanoma_006,,,,,,,Primary Melanoma_006,GSM1526025,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 30(time to 1st recurrence (days): 1093(time to 1st recurrence (months): 36(time to b-met (days): NA(follow-up time (days): 1356(follow-up time (months): 44,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526025/suppl/GSM1526025_0_Exiqon_14257929_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526025/suppl/GSM1526025_1_Exiqon_14257929_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526025,006,M,77,Few,Absent,Desmoplastic,Extremity,IIIA,Y,"RLN ,RS",N,N,"Died, With Melanoma",Melanoma
primary_melanoma_007,,,,,,,Primary Melanoma_007,GSM1526026,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.6(time to 1st recurrence (days): 1011(time to 1st recurrence (months): 33(time to b-met (days): 1011(follow-up time (days): 1030(follow-up time (months): 33,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526026/suppl/GSM1526026_0_Exiqon_14257946_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526026/suppl/GSM1526026_1_Exiqon_14257946_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526026,007,M,73,Few,Absent,Nodular,Axial,IIA,Y,DV,Y,Y,"Died, With Melanoma",Melanoma
primary_melanoma_008,,,,,,,Primary Melanoma_008,GSM1526027,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 5.1(time to 1st recurrence (days): 385(time to 1st recurrence (months): 13(time to b-met (days): NA(follow-up time (days): 601(follow-up time (months): 19,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526027/suppl/GSM1526027_0_Exiqon_14257935_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526027/suppl/GSM1526027_1_Exiqon_14257935_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526027,008,M,72,Many,Present,Nodular,Extremity,IIC,Y,RS,N,N,"Died, No Melanoma",Adenocarcinoma
primary_melanoma_009,,,,,,,Primary Melanoma_009,GSM1526028,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3793(follow-up time (months): 124,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526028/suppl/GSM1526028_0_Exiqon_14257948_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526028/suppl/GSM1526028_1_Exiqon_14257948_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526028,009,F,61,Moderate,Absent,Nodular,Extremity,IIIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_010,,,,,,,Primary Melanoma_010,GSM1526029,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 10(time to 1st recurrence (days): 573(time to 1st recurrence (months): 18(time to b-met (days): 1734(follow-up time (days): 1953(follow-up time (months): 64,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526029/suppl/GSM1526029_0_Exiqon_14257898_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526029/suppl/GSM1526029_1_Exiqon_14257898_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526029,010,M,57,Many,Present,Nodular,Axial,IIC,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_011,,,,,,,Primary Melanoma_011,GSM1526030,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 12(time to 1st recurrence (days): 642(time to 1st recurrence (months): 21(time to b-met (days): NA(follow-up time (days): 1105(follow-up time (months): 36,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526030/suppl/GSM1526030_0_Exiqon_14257824_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526030/suppl/GSM1526030_1_Exiqon_14257824_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526030,011,M,66,Moderate,Present,Nodular,Axial,IIIC,Y,DS,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_012,,,,,,,Primary Melanoma_012,GSM1526031,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.1(time to 1st recurrence (days): 2143(time to 1st recurrence (months): 71(time to b-met (days): NA(follow-up time (days): 2284(follow-up time (months): 75,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526031/suppl/GSM1526031_0_Exiqon_14258013_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526031/suppl/GSM1526031_1_Exiqon_14258013_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526031,012,M,70,Few,Absent,Acral Lentiginous,Extremity,IB,Y,RLN,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_013,,,,,,,Primary Melanoma_013,GSM1526032,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.62(time to 1st recurrence (days): 316(time to 1st recurrence (months): 10(time to b-met (days): NA(follow-up time (days): 1096(follow-up time (months): 36,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526032/suppl/GSM1526032_0_Exiqon_14257879_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526032/suppl/GSM1526032_1_Exiqon_14257879_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526032,013,M,51,Many,Absent,Superficial Spreading,Axial,IIIA,Y,RLN,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_014,,,,,,,Primary Melanoma_014,GSM1526033,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 10(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 378(follow-up time (months): 12,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526033/suppl/GSM1526033_0_Exiqon_14257860_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526033/suppl/GSM1526033_1_Exiqon_14257860_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526033,014,F,83,Moderate,Present,Nodular,Extremity,IIC,N,NA,N,N,"Died, Melanoma Status Unknown",Unknown
primary_melanoma_015,,,,,,,Primary Melanoma_015,GSM1526034,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 5(time to 1st recurrence (days): 830(time to 1st recurrence (months): 27(time to b-met (days): 1085(follow-up time (days): 1196(follow-up time (months): 39,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526034/suppl/GSM1526034_0_Exiqon_14257921_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526034/suppl/GSM1526034_1_Exiqon_14257921_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526034,015,M,77,Few,Present,Acral Lentiginous,Extremity,IIC,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_016,,,,,,,Primary Melanoma_016,GSM1526035,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.65(time to 1st recurrence (days): 167(time to 1st recurrence (months): 6(time to b-met (days): 403(follow-up time (days): 471(follow-up time (months): 15,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526035/suppl/GSM1526035_0_Exiqon_14258003_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526035/suppl/GSM1526035_1_Exiqon_14258003_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526035,016,M,81,Many,Present,Nodular,Extremity,IIB,Y,"RLN , RS",N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_017,,,,,,,Primary Melanoma_017,GSM1526036,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.3(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3202(follow-up time (months): 105,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526036/suppl/GSM1526036_0_Exiqon_14257848_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526036/suppl/GSM1526036_1_Exiqon_14257848_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526036,017,F,80,Few,Present,Nodular,Axial,IIIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_018,,,,,,,Primary Melanoma_018,GSM1526037,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.85(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1453(follow-up time (months): 47,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526037/suppl/GSM1526037_0_Exiqon_14257823_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526037/suppl/GSM1526037_1_Exiqon_14257823_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526037,018,M,71,Many,Absent,Nodular,Axial,IIIB,N,NA,N,N,"Died, No Melanoma",Old Age
primary_melanoma_019,,,,,,,Primary Melanoma_019,GSM1526038,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 0.72(time to 1st recurrence (days): 3497(time to 1st recurrence (months): 115(time to b-met (days): 3703(follow-up time (days): 3735(follow-up time (months): 122,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526038/suppl/GSM1526038_0_Exiqon_14257938_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526038/suppl/GSM1526038_1_Exiqon_14257938_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526038,019,F,43,None,Absent,Superficial Spreading,Axial,IA,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_020,,,,,,,Primary Melanoma_020,GSM1526039,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 6(time to 1st recurrence (days): 1463(time to 1st recurrence (months): 48(time to b-met (days): NA(follow-up time (days): 5119(follow-up time (months): 168,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526039/suppl/GSM1526039_0_Exiqon_14257959_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526039/suppl/GSM1526039_1_Exiqon_14257959_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526039,020,M,74,Few,Absent,Superficial Spreading,Axial,IIB,Y,LR,N,N,"Alive, No Melanoma",NA
primary_melanoma_021,,,,,,,Primary Melanoma_021,GSM1526040,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 24(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 3185(follow-up time (months): 104,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526040/suppl/GSM1526040_0_Exiqon_14257830_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526040/suppl/GSM1526040_1_Exiqon_14257830_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526040,021,M,54,Many,Present,Nodular,Extremity,IIIC,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_022,,,,,,,Primary Melanoma_022,GSM1526041,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 13(time to 1st recurrence (days): 928(time to 1st recurrence (months): 30(time to b-met (days): NA(follow-up time (days): 3763(follow-up time (months): 123,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526041/suppl/GSM1526041_0_Exiqon_14257899_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526041/suppl/GSM1526041_1_Exiqon_14257899_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526041,022,M,76,Few,Present,Superficial Spreading,Axial,IIIC,Y,RS,N,N,"Alive, No Melanoma",NA
primary_melanoma_023,,,,,,,Primary Melanoma_023,GSM1526042,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 5.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2513(follow-up time (months): 82,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526042/suppl/GSM1526042_0_Exiqon_14257970_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526042/suppl/GSM1526042_1_Exiqon_14257970_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526042,023,F,53,Many,Absent,Nodular,Extremity,IIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_024,,,,,,,Primary Melanoma_024,GSM1526043,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.9(time to 1st recurrence (days): 1999(time to 1st recurrence (months): 66(time to b-met (days): NA(follow-up time (days): 5081(follow-up time (months): 166,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526043/suppl/GSM1526043_0_Exiqon_14257877_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526043/suppl/GSM1526043_1_Exiqon_14257877_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526043,024,M,55,Moderate,Absent,Desmoplastic,Axial,IIA,Y,RLN,N,N,"Alive, No Melanoma",NA
primary_melanoma_025,,,,,,,Primary Melanoma_025,GSM1526044,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 6(time to 1st recurrence (days): 201(time to 1st recurrence (months): 7(time to b-met (days): NA(follow-up time (days): 440(follow-up time (months): 14,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526044/suppl/GSM1526044_0_Exiqon_14258006_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526044/suppl/GSM1526044_1_Exiqon_14258006_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526044,025,M,91,Many,Present,Superficial Spreading,Axial,IIIB,Y,"RLN , RS",N,N,"Died, With Melanoma",Melanoma
primary_melanoma_026,,,,,,,Primary Melanoma_026,GSM1526045,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.4(time to 1st recurrence (days): 532(time to 1st recurrence (months): 18(time to b-met (days): NA(follow-up time (days): 665(follow-up time (months): 21,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526045/suppl/GSM1526045_0_Exiqon_14257892_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526045/suppl/GSM1526045_1_Exiqon_14257892_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526045,026,F,62,Few,Present,Acral Lentiginous,Extremity,IIA,Y,"RLN , RS",N,N,"Died, With Melanoma",Melanoma
primary_melanoma_027,,,,,,,Primary Melanoma_027,GSM1526046,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.9(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2801(follow-up time (months): 92,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526046/suppl/GSM1526046_0_Exiqon_14257846_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526046/suppl/GSM1526046_1_Exiqon_14257846_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526046,027,F,75,Many,Present,Nodular,Extremity,IIC,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_028,,,,,,,Primary Melanoma_028,GSM1526047,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 8(time to 1st recurrence (days): 56(time to 1st recurrence (months): 2(time to b-met (days): 228(follow-up time (days): 267(follow-up time (months): 8,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526047/suppl/GSM1526047_0_Exiqon_14257833_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526047/suppl/GSM1526047_1_Exiqon_14257833_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526047,028,M,42,Many,Present,Nodular,Axial,IV,Y,DS,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_029,,,,,,,Primary Melanoma_029,GSM1526048,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 11.5(time to 1st recurrence (days): 220(time to 1st recurrence (months): 7(time to b-met (days): 220(follow-up time (days): 1740(follow-up time (months): 57,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526048/suppl/GSM1526048_0_Exiqon_14257858_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526048/suppl/GSM1526048_1_Exiqon_14257858_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526048,029,M,28,Moderate,Present,Nodular,Axial,IIIC,Y,DV,Y,Y,"Died, With Melanoma",Melanoma
primary_melanoma_030,,,,,,,Primary Melanoma_030,GSM1526049,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.7(time to 1st recurrence (days): 127(time to 1st recurrence (months): 4(time to b-met (days): 336(follow-up time (days): 368(follow-up time (months): 12,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526049/suppl/GSM1526049_0_Exiqon_14257878_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526049/suppl/GSM1526049_1_Exiqon_14257878_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526049,030,M,52,Moderate,Absent,Superficial Spreading,Axial,IIIC,Y,LR,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_031,,,,,,,Primary Melanoma_031,GSM1526050,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 6.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1949(follow-up time (months): 64,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526050/suppl/GSM1526050_0_Exiqon_14257973_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526050/suppl/GSM1526050_1_Exiqon_14257973_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526050,031,M,90,Moderate,Present,Nodular,Axial,IIC,N,NA,N,N,"Died, No Melanoma",Natural Causes
primary_melanoma_032,,,,,,,Primary Melanoma_032,GSM1526051,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.48(time to 1st recurrence (days): 741(time to 1st recurrence (months): 25(time to b-met (days): 1209(follow-up time (days): 1351(follow-up time (months): 44,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526051/suppl/GSM1526051_0_Exiqon_14257988_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526051/suppl/GSM1526051_1_Exiqon_14257988_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526051,032,F,65,Moderate,Present,Superficial Spreading,Axial,IIIB,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_033,,,,,,,Primary Melanoma_033,GSM1526052,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.06(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2266(follow-up time (months): 74,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526052/suppl/GSM1526052_0_Exiqon_14257949_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526052/suppl/GSM1526052_1_Exiqon_14257949_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526052,033,M,73,Few,Absent,Superficial Spreading,Axial,IIIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_034,,,,,,,Primary Melanoma_034,GSM1526053,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 5(time to 1st recurrence (days): 477(time to 1st recurrence (months): 16(time to b-met (days): NA(follow-up time (days): 1483(follow-up time (months): 48,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526053/suppl/GSM1526053_0_Exiqon_14257825_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526053/suppl/GSM1526053_1_Exiqon_14257825_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526053,034,M,53,Many,Present,Nodular,Axial,IIIC,Y,RS,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_035,,,,,,,Primary Melanoma_035,GSM1526054,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 8(time to 1st recurrence (days): 1945(time to 1st recurrence (months): 63(time to b-met (days): NA(follow-up time (days): 2546(follow-up time (months): 83,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526054/suppl/GSM1526054_0_Exiqon_14257915_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526054/suppl/GSM1526054_1_Exiqon_14257915_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526054,035,F,30,Few,Absent,Desmoplastic,Axial,IIB,Y,DV,N,N,"Alive, No Melanoma",NA
primary_melanoma_036,,,,,,,Primary Melanoma_036,GSM1526055,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.87(time to 1st recurrence (days): 357(time to 1st recurrence (months): 12(time to b-met (days): NA(follow-up time (days): 363(follow-up time (months): 11,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526055/suppl/GSM1526055_0_Exiqon_14257983_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526055/suppl/GSM1526055_1_Exiqon_14257983_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526055,036,M,62,Many,Present,Nodular,Axial,IIIB,Y,DV,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_037,,,,,,,Primary Melanoma_037,GSM1526056,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.12(time to 1st recurrence (days): 2006(time to 1st recurrence (months): 66(time to b-met (days): 2006(follow-up time (days): 2155(follow-up time (months): 70,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526056/suppl/GSM1526056_0_Exiqon_14257844_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526056/suppl/GSM1526056_1_Exiqon_14257844_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526056,037,M,54,None,Absent,Superficial Spreading,Axial,IB,Y,DV,Y,Y,"Died, With Melanoma",Melanoma
primary_melanoma_038,,,,,,,Primary Melanoma_038,GSM1526057,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.49(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 791(follow-up time (months): 25,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526057/suppl/GSM1526057_0_Exiqon_14257912_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526057/suppl/GSM1526057_1_Exiqon_14257912_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526057,038,M,88,Many,Absent,Nodular,Axial,IIA,N,NA,N,N,"Died, No Melanoma",Other
primary_melanoma_039,,,,,,,Primary Melanoma_039,GSM1526058,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4(time to 1st recurrence (days): 553(time to 1st recurrence (months): 19(time to b-met (days): NA(follow-up time (days): 1695(follow-up time (months): 55,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526058/suppl/GSM1526058_0_Exiqon_14257976_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526058/suppl/GSM1526058_1_Exiqon_14257976_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526058,039,M,65,Many,Present,Nodular,Extremity,IIIB,Y,RS,N,N,"Alive, No Melanoma",NA
primary_melanoma_040,,,,,,,Primary Melanoma_040,GSM1526059,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 12(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2322(follow-up time (months): 76,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526059/suppl/GSM1526059_0_Exiqon_14257865_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526059/suppl/GSM1526059_1_Exiqon_14257865_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526059,040,M,51,Many,Absent,Other,Axial,IIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_041,,,,,,,Primary Melanoma_041,GSM1526060,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 7(time to 1st recurrence (days): 886(time to 1st recurrence (months): 29(time to b-met (days): NA(follow-up time (days): 2486(follow-up time (months): 81,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526060/suppl/GSM1526060_0_Exiqon_14257972_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526060/suppl/GSM1526060_1_Exiqon_14257972_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526060,041,M,72,Many,Present,Nodular,Axial,IIIC,Y,DV,N,N,"Alive, No Melanoma",NA
primary_melanoma_042,,,,,,,Primary Melanoma_042,GSM1526061,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.6(time to 1st recurrence (days): 620(time to 1st recurrence (months): 20(time to b-met (days): 826(follow-up time (days): 920(follow-up time (months): 30,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526061/suppl/GSM1526061_0_Exiqon_14257918_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526061/suppl/GSM1526061_1_Exiqon_14257918_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526061,042,M,53,Few,Present,Superficial Spreading,Axial,IIIB,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_043,,,,,,,Primary Melanoma_043,GSM1526062,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.9(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2296(follow-up time (months): 75,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526062/suppl/GSM1526062_0_Exiqon_14257829_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526062/suppl/GSM1526062_1_Exiqon_14257829_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526062,043,M,54,Few,Present,Superficial Spreading,Axial,IIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_044,,,,,,,Primary Melanoma_044,GSM1526063,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.5(time to 1st recurrence (days): 1348(time to 1st recurrence (months): 45(time to b-met (days): NA(follow-up time (days): 2200(follow-up time (months): 72,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526063/suppl/GSM1526063_0_Exiqon_14257855_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526063/suppl/GSM1526063_1_Exiqon_14257855_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526063,044,F,40,Moderate,Present,Acral Lentiginous,Extremity,IIIB,Y,DLN,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_045,,,,,,,Primary Melanoma_045,GSM1526064,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.7(time to 1st recurrence (days): 408(time to 1st recurrence (months): 13(time to b-met (days): NA(follow-up time (days): 757(follow-up time (months): 24,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526064/suppl/GSM1526064_0_Exiqon_14257987_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526064/suppl/GSM1526064_1_Exiqon_14257987_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526064,045,F,91,Many,Absent,Nodular,Extremity,IIIB,Y,RS,N,N,"Died, No Melanoma",Other
primary_melanoma_046,,,,,,,Primary Melanoma_046,GSM1526065,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.25(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1461(follow-up time (months): 48,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526065/suppl/GSM1526065_0_Exiqon_14257845_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526065/suppl/GSM1526065_1_Exiqon_14257845_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526065,046,F,60,Few,Absent,Superficial Spreading,Extremity,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_047,,,,,,,Primary Melanoma_047,GSM1526066,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.6(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1363(follow-up time (months): 44,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526066/suppl/GSM1526066_0_Exiqon_14257851_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526066/suppl/GSM1526066_1_Exiqon_14257851_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526066,047,M,69,Moderate,Absent,Superficial Spreading,Extremity,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_048,,,,,,,Primary Melanoma_048,GSM1526067,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3(time to 1st recurrence (days): 479(time to 1st recurrence (months): 16(time to b-met (days): NA(follow-up time (days): 984(follow-up time (months): 32,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526067/suppl/GSM1526067_0_Exiqon_14257943_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526067/suppl/GSM1526067_1_Exiqon_14257943_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526067,048,F,64,Moderate,Present,Acral Lentiginous,Extremity,IIIB,Y,RS,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_049,,,,,,,Primary Melanoma_049,GSM1526068,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 6(time to 1st recurrence (days): 302(time to 1st recurrence (months): 10(time to b-met (days): NA(follow-up time (days): 471(follow-up time (months): 15,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526068/suppl/GSM1526068_0_Exiqon_14257884_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526068/suppl/GSM1526068_1_Exiqon_14257884_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526068,049,M,89,Few,Absent,Nodular,Extremity,IIIB,Y,DS,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_050,,,,,,,Primary Melanoma_050,GSM1526069,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1520(follow-up time (months): 49,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526069/suppl/GSM1526069_0_Exiqon_14258008_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526069/suppl/GSM1526069_1_Exiqon_14258008_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526069,050,F,69,Many,Present,Nodular,Extremity,IIC,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_051,,,,,,,Primary Melanoma_051,GSM1526070,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 8(time to 1st recurrence (days): 454(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 728(follow-up time (months): 23,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526070/suppl/GSM1526070_0_Exiqon_14257924_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526070/suppl/GSM1526070_1_Exiqon_14257924_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526070,051,M,42,Many,Absent,Nodular,Axial,IIIA,Y,DV,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_052,,,,,,,Primary Melanoma_052,GSM1526071,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.8(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1597(follow-up time (months): 52,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526071/suppl/GSM1526071_0_Exiqon_14257841_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526071/suppl/GSM1526071_1_Exiqon_14257841_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526071,052,F,80,Few,Present,Nodular,Extremity,IIC,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_053,,,,,,,Primary Melanoma_053,GSM1526072,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2(time to 1st recurrence (days): 222(time to 1st recurrence (months): 8(time to b-met (days): 476(follow-up time (days): 667(follow-up time (months): 21,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526072/suppl/GSM1526072_0_Exiqon_14257866_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526072/suppl/GSM1526072_1_Exiqon_14257866_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526072,053,M,58,Few,Absent,Nodular,Axial,IIIA,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_054,,,,,,,Primary Melanoma_054,GSM1526073,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 0.85(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1995(follow-up time (months): 65,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526073/suppl/GSM1526073_0_Exiqon_14257847_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526073/suppl/GSM1526073_1_Exiqon_14257847_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526073,054,F,67,None,Absent,Superficial Spreading,Extremity,IA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_055,,,,,,,Primary Melanoma_055,GSM1526074,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.85(time to 1st recurrence (days): 1841(time to 1st recurrence (months): 60(time to b-met (days): 2433(follow-up time (days): 2463(follow-up time (months): 80,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526074/suppl/GSM1526074_0_Exiqon_14257893_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526074/suppl/GSM1526074_1_Exiqon_14257893_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526074,055,F,56,Moderate,Absent,Acral Lentiginous,Extremity,IB,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_056,,,,,,,Primary Melanoma_056,GSM1526075,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 5(time to 1st recurrence (days): 259(time to 1st recurrence (months): 8(time to b-met (days): NA(follow-up time (days): 585(follow-up time (months): 19,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526075/suppl/GSM1526075_0_Exiqon_14257961_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526075/suppl/GSM1526075_1_Exiqon_14257961_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526075,056,M,50,Moderate,Present,Nodular,Axial,IIIC,Y,RS,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_057,,,,,,,Primary Melanoma_057,GSM1526076,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.5(time to 1st recurrence (days): 912(time to 1st recurrence (months): 30(time to b-met (days): 1006(follow-up time (days): 1163(follow-up time (months): 38,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526076/suppl/GSM1526076_0_Exiqon_14257826_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526076/suppl/GSM1526076_1_Exiqon_14257826_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526076,057,F,52,Few,Absent,Superficial Spreading,Axial,IIA,Y,DS,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_058,,,,,,,Primary Melanoma_058,GSM1526077,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1756(follow-up time (months): 57,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526077/suppl/GSM1526077_0_Exiqon_14257936_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526077/suppl/GSM1526077_1_Exiqon_14257936_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526077,058,F,78,Few,Present,Nodular,Axial,IIB,N,NA,N,N,"Died, No Melanoma",Other
primary_melanoma_059,,,,,,,Primary Melanoma_059,GSM1526078,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.4(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2108(follow-up time (months): 69,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526078/suppl/GSM1526078_0_Exiqon_14258004_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526078/suppl/GSM1526078_1_Exiqon_14258004_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526078,059,M,56,None,Present,Superficial Spreading,Axial,IIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_060,,,,,,,Primary Melanoma_060,GSM1526079,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.1(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1026(follow-up time (months): 33,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526079/suppl/GSM1526079_0_Exiqon_14257840_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526079/suppl/GSM1526079_1_Exiqon_14257840_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526079,060,M,76,Few,Absent,Nodular,Axial,IIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_061,,,,,,,Primary Melanoma_061,GSM1526080,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4(time to 1st recurrence (days): 181(time to 1st recurrence (months): 6(time to b-met (days): 726(follow-up time (days): 873(follow-up time (months): 28,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526080/suppl/GSM1526080_0_Exiqon_14257852_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526080/suppl/GSM1526080_1_Exiqon_14257852_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526080,061,M,65,Many,Present,Nodular,Axial,IIIB,Y,RS,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_062,,,,,,,Primary Melanoma_062,GSM1526081,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4(time to 1st recurrence (days): 892(time to 1st recurrence (months): 29(time to b-met (days): 1393(follow-up time (days): 1507(follow-up time (months): 49,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526081/suppl/GSM1526081_0_Exiqon_14257863_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526081/suppl/GSM1526081_1_Exiqon_14257863_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526081,062,M,74,Many,Present,Nodular,Extremity,IIIB,Y,RS,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_063,,,,,,,Primary Melanoma_063,GSM1526082,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1850(follow-up time (months): 60,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526082/suppl/GSM1526082_0_Exiqon_14257828_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526082/suppl/GSM1526082_1_Exiqon_14257828_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526082,063,M,71,Many,Present,Nodular,Axial,IIIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_064,,,,,,,Primary Melanoma_064,GSM1526083,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.13(time to 1st recurrence (days): 455(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 1763(follow-up time (months): 57,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526083/suppl/GSM1526083_0_Exiqon_14257882_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526083/suppl/GSM1526083_1_Exiqon_14257882_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526083,064,M,78,Many,Present,Superficial Spreading,Axial,IIA,Y,RLN,N,N,"Alive, With Melanoma",NA
primary_melanoma_065,,,,,,,Primary Melanoma_065,GSM1526084,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.8(time to 1st recurrence (days): 358(time to 1st recurrence (months): 11(time to b-met (days): 762(follow-up time (days): 1259(follow-up time (months): 41,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526084/suppl/GSM1526084_0_Exiqon_14257985_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526084/suppl/GSM1526084_1_Exiqon_14257985_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526084,065,F,53,Few,Absent,Acral Lentiginous,Extremity,IIIA,Y,RS,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_066,,,,,,,Primary Melanoma_066,GSM1526085,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1090(follow-up time (months): 35,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526085/suppl/GSM1526085_0_Exiqon_14257831_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526085/suppl/GSM1526085_1_Exiqon_14257831_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526085,066,M,30,Few,Present,Nodular,Extremity,IIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_067,,,,,,,Primary Melanoma_067,GSM1526086,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.85(time to 1st recurrence (days): 430(time to 1st recurrence (months): 14(time to b-met (days): NA(follow-up time (days): 1133(follow-up time (months): 37,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526086/suppl/GSM1526086_0_Exiqon_14257837_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526086/suppl/GSM1526086_1_Exiqon_14257837_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526086,067,F,56,None,Absent,Superficial Spreading,Axial,IB,Y,RLN,N,N,"Died, Melanoma Status Unknown",Unknown
primary_melanoma_068,,,,,,,Primary Melanoma_068,GSM1526087,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.5(time to 1st recurrence (days): 710(time to 1st recurrence (months): 23(time to b-met (days): 726(follow-up time (days): 889(follow-up time (months): 29,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526087/suppl/GSM1526087_0_Exiqon_14257868_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526087/suppl/GSM1526087_1_Exiqon_14257868_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526087,068,M,72,Few,Present,Nodular,Axial,IIB,Y,LR,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_069,,,,,,,Primary Melanoma_069,GSM1526088,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.8(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 868(follow-up time (months): 28,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526088/suppl/GSM1526088_0_Exiqon_14257835_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526088/suppl/GSM1526088_1_Exiqon_14257835_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526088,069,F,39,Few,Absent,Superficial Spreading,Axial,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_070,,,,,,,Primary Melanoma_070,GSM1526089,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1254(follow-up time (months): 41,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526089/suppl/GSM1526089_0_Exiqon_14257788_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526089/suppl/GSM1526089_1_Exiqon_14257788_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526089,070,M,88,Moderate,Present,Nodular,Axial,IIC,N,NA,N,N,"Died, No Melanoma",Other
primary_melanoma_071,,,,,,,Primary Melanoma_071,GSM1526090,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1492(follow-up time (months): 49,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526090/suppl/GSM1526090_0_Exiqon_14257965_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526090/suppl/GSM1526090_1_Exiqon_14257965_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526090,071,M,81,Few,Absent,Superficial Spreading,Axial,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_072,,,,,,,Primary Melanoma_072,GSM1526091,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 0.85(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1415(follow-up time (months): 46,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526091/suppl/GSM1526091_0_Exiqon_14257849_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526091/suppl/GSM1526091_1_Exiqon_14257849_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526091,072,M,65,None,Absent,Superficial Spreading,Axial,IA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_073,,,,,,,Primary Melanoma_073,GSM1526092,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.88(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1023(follow-up time (months): 33,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526092/suppl/GSM1526092_0_Exiqon_14258009_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526092/suppl/GSM1526092_1_Exiqon_14258009_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526092,073,F,37,Few,Present,Superficial Spreading,Axial,IIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_074,,,,,,,Primary Melanoma_074,GSM1526093,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.25(time to 1st recurrence (days): 1283(time to 1st recurrence (months): 42(time to b-met (days): NA(follow-up time (days): 1315(follow-up time (months): 43,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526093/suppl/GSM1526093_0_Exiqon_14257967_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526093/suppl/GSM1526093_1_Exiqon_14257967_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526093,074,M,64,None,Absent,Superficial Spreading,Axial,IIIA,Y,DV,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_075,,,,,,,Primary Melanoma_075,GSM1526094,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 5.5(time to 1st recurrence (days): 561(time to 1st recurrence (months): 18(time to b-met (days): NA(follow-up time (days): 862(follow-up time (months): 28,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526094/suppl/GSM1526094_0_Exiqon_14258012_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526094/suppl/GSM1526094_1_Exiqon_14258012_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526094,075,F,78,Moderate,Present,Nodular,Extremity,IIC,Y,DS,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_076,,,,,,,Primary Melanoma_076,GSM1526095,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 0.52(time to 1st recurrence (days): 2302(time to 1st recurrence (months): 75(time to b-met (days): 2319(follow-up time (days): 2817(follow-up time (months): 92,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526095/suppl/GSM1526095_0_Exiqon_14257928_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526095/suppl/GSM1526095_1_Exiqon_14257928_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526095,076,M,66,Few,Absent,Superficial Spreading,Axial,IB,Y,RS,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_077,,,,,,,Primary Melanoma_077,GSM1526096,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1668(follow-up time (months): 54,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526096/suppl/GSM1526096_0_Exiqon_14257923_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526096/suppl/GSM1526096_1_Exiqon_14257923_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526096,077,F,78,Few,Absent,Superficial Spreading,Extremity,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_078,,,,,,,Primary Melanoma_078,GSM1526097,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.2(time to 1st recurrence (days): 177(time to 1st recurrence (months): 6(time to b-met (days): NA(follow-up time (days): 345(follow-up time (months): 11,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526097/suppl/GSM1526097_0_Exiqon_14257979_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526097/suppl/GSM1526097_1_Exiqon_14257979_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526097,078,F,61,Many,Absent,Nodular,Extremity,IIIC,Y,DV,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_079,,,,,,,Primary Melanoma_079,GSM1526098,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1708(follow-up time (months): 56,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526098/suppl/GSM1526098_0_Exiqon_14257941_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526098/suppl/GSM1526098_1_Exiqon_14257941_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526098,079,M,56,Few,Absent,Superficial Spreading,Axial,IIIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_080,,,,,,,Primary Melanoma_080,GSM1526099,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 10(time to 1st recurrence (days): 1086(time to 1st recurrence (months): 36(time to b-met (days): NA(follow-up time (days): 2703(follow-up time (months): 88,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526099/suppl/GSM1526099_0_Exiqon_14258007_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526099/suppl/GSM1526099_1_Exiqon_14258007_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526099,080,M,50,Few,Absent,Nodular,Extremity,IIIB,Y,RS,N,N,"Alive, No Melanoma",NA
primary_melanoma_081,,,,,,,Primary Melanoma_081,GSM1526100,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.05(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 596(follow-up time (months): 19,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526100/suppl/GSM1526100_0_Exiqon_14257854_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526100/suppl/GSM1526100_1_Exiqon_14257854_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526100,081,M,86,Few,Absent,Nodular,Axial,IIA,N,NA,N,N,"Died, No Melanoma",Other
primary_melanoma_082,,,,,,,Primary Melanoma_082,GSM1526101,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 8(time to 1st recurrence (days): 629(time to 1st recurrence (months): 20(time to b-met (days): NA(follow-up time (days): 778(follow-up time (months): 25,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526101/suppl/GSM1526101_0_Exiqon_14257933_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526101/suppl/GSM1526101_1_Exiqon_14257933_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526101,082,M,81,None,Present,Desmoplastic,Axial,IIC,Y,RS,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_083,,,,,,,Primary Melanoma_083,GSM1526102,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 904(follow-up time (months): 29,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526102/suppl/GSM1526102_0_Exiqon_14258010_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526102/suppl/GSM1526102_1_Exiqon_14258010_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526102,083,F,65,Moderate,Absent,Nodular,Extremity,IIIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_084,,,,,,,Primary Melanoma_084,GSM1526103,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 838(follow-up time (months): 27,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526103/suppl/GSM1526103_0_Exiqon_14257883_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526103/suppl/GSM1526103_1_Exiqon_14257883_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526103,084,F,86,None,Present,Superficial Spreading,Extremity,IIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_085,,,,,,,Primary Melanoma_085,GSM1526104,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 0.89(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 836(follow-up time (months): 27,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526104/suppl/GSM1526104_0_Exiqon_14257871_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526104/suppl/GSM1526104_1_Exiqon_14257871_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526104,085,F,20,Few,Present,Nodular,Extremity,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_086,,,,,,,Primary Melanoma_086,GSM1526105,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.25(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1518(follow-up time (months): 49,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526105/suppl/GSM1526105_0_Exiqon_14257839_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526105/suppl/GSM1526105_1_Exiqon_14257839_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526105,086,F,44,Few,Absent,Nodular,Axial,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_087,,,,,,,Primary Melanoma_087,GSM1526106,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3(time to 1st recurrence (days): 455(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 1580(follow-up time (months): 51,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526106/suppl/GSM1526106_0_Exiqon_14257947_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526106/suppl/GSM1526106_1_Exiqon_14257947_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526106,087,M,82,None,Present,Acral Lentiginous,Extremity,IIB,Y,RS,N,N,"Alive, With Melanoma",NA
primary_melanoma_088,,,,,,,Primary Melanoma_088,GSM1526107,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.24(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1575(follow-up time (months): 51,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526107/suppl/GSM1526107_0_Exiqon_14257881_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526107/suppl/GSM1526107_1_Exiqon_14257881_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526107,088,M,70,Few,Absent,Superficial Spreading,Axial,IIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_089,,,,,,,Primary Melanoma_089,GSM1526108,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 13(time to 1st recurrence (days): 1189(time to 1st recurrence (months): 39(time to b-met (days): 1659(follow-up time (days): 1733(follow-up time (months): 57,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526108/suppl/GSM1526108_0_Exiqon_14257875_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526108/suppl/GSM1526108_1_Exiqon_14257875_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526108,089,M,28,Few,Absent,Nodular,Extremity,IIIC,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_090,,,,,,,Primary Melanoma_090,GSM1526109,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3(time to 1st recurrence (days): 1530(time to 1st recurrence (months): 50(time to b-met (days): 1673(follow-up time (days): 2041(follow-up time (months): 67,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526109/suppl/GSM1526109_0_Exiqon_14257880_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526109/suppl/GSM1526109_1_Exiqon_14257880_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526109,090,M,48,Moderate,Absent,Nodular,Axial,IIA,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_091,,,,,,,Primary Melanoma_091,GSM1526110,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.37(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1172(follow-up time (months): 38,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526110/suppl/GSM1526110_0_Exiqon_14257859_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526110/suppl/GSM1526110_1_Exiqon_14257859_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526110,091,M,63,Few,Absent,Superficial Spreading,Axial,IB,N,NA,N,N,"Died, No Melanoma",Other
primary_melanoma_092,,,,,,,Primary Melanoma_092,GSM1526111,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.15(time to 1st recurrence (days): 469(time to 1st recurrence (months): 15(time to b-met (days): NA(follow-up time (days): 1519(follow-up time (months): 49,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526111/suppl/GSM1526111_0_Exiqon_14257874_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526111/suppl/GSM1526111_1_Exiqon_14257874_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526111,092,F,66,Moderate,Present,Acral Lentiginous,Axial,IIIB,Y,RS,N,N,"Alive, No Melanoma",NA
primary_melanoma_093,,,,,,,Primary Melanoma_093,GSM1526112,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 8.5(time to 1st recurrence (days): 83(time to 1st recurrence (months): 2(time to b-met (days): NA(follow-up time (days): 226(follow-up time (months): 7,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526112/suppl/GSM1526112_0_Exiqon_14257986_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526112/suppl/GSM1526112_1_Exiqon_14257986_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526112,093,F,40,Many,Present,Nodular,Axial,IIIC,Y,DV,N,N,"Died, With Melanoma",Melanom
primary_melanoma_094,,,,,,,Primary Melanoma_094,GSM1526113,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4(time to 1st recurrence (days): 553(time to 1st recurrence (months): 19(time to b-met (days): NA(follow-up time (days): 1497(follow-up time (months): 49,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526113/suppl/GSM1526113_0_Exiqon_14257945_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526113/suppl/GSM1526113_1_Exiqon_14257945_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526113,094,M,58,Moderate,Absent,Superficial Spreading,Axial,IIA,Y,DV,N,N,"Alive, No Melanoma",NA
primary_melanoma_095,,,,,,,Primary Melanoma_095,GSM1526114,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.37(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 720(follow-up time (months): 23,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526114/suppl/GSM1526114_0_Exiqon_14257890_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526114/suppl/GSM1526114_1_Exiqon_14257890_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526114,095,F,50,Few,Absent,Acral Lentiginous,Extremity,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_096,,,,,,,Primary Melanoma_096,GSM1526115,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 7(time to 1st recurrence (days): 3(time to 1st recurrence (months): 0(time to b-met (days): 3(follow-up time (days): 567(follow-up time (months): 18,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526115/suppl/GSM1526115_0_Exiqon_14257834_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526115/suppl/GSM1526115_1_Exiqon_14257834_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526115,096,M,56,Moderate,Present,Nodular,Axial,IV,Y,DV,Y,Y,"Died, With Melanoma",Melanoma
primary_melanoma_097,,,,,,,Primary Melanoma_097,GSM1526116,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.55(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1486(follow-up time (months): 48,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526116/suppl/GSM1526116_0_Exiqon_14257978_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526116/suppl/GSM1526116_1_Exiqon_14257978_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526116,097,F,42,Many,Present,Nodular,Extremity,IIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_098,,,,,,,Primary Melanoma_098,GSM1526117,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1358(follow-up time (months): 44,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526117/suppl/GSM1526117_0_Exiqon_14257964_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526117/suppl/GSM1526117_1_Exiqon_14257964_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526117,098,M,49,Few,Present,Superficial Spreading,Axial,IIIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_099,,,,,,,Primary Melanoma_099,GSM1526118,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4(time to 1st recurrence (days): 901(time to 1st recurrence (months): 29(time to b-met (days): 1240(follow-up time (days): 1252(follow-up time (months): 41,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526118/suppl/GSM1526118_0_Exiqon_14258011_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526118/suppl/GSM1526118_1_Exiqon_14258011_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526118,099,F,81,Moderate,Present,Superficial Spreading,Axial,IIIB,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_100,,,,,,,Primary Melanoma_100,GSM1526119,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.3(time to 1st recurrence (days): 588(time to 1st recurrence (months): 20(time to b-met (days): 588(follow-up time (days): 1407(follow-up time (months): 46,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526119/suppl/GSM1526119_0_Exiqon_14257930_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526119/suppl/GSM1526119_1_Exiqon_14257930_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526119,100,M,65,Few,Present,Nodular,Axial,IIC,Y,DV,Y,Y,"Alive, With Melanoma",NA
primary_melanoma_101,,,,,,,Primary Melanoma_101,GSM1526120,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.2(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 848(follow-up time (months): 27,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526120/suppl/GSM1526120_0_Exiqon_14257896_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526120/suppl/GSM1526120_1_Exiqon_14257896_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526120,101,F,72,Many,Absent,Superficial Spreading,Extremity,IB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_102,,,,,,,Primary Melanoma_102,GSM1526121,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.95(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1326(follow-up time (months): 43,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526121/suppl/GSM1526121_0_Exiqon_14257950_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526121/suppl/GSM1526121_1_Exiqon_14257950_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526121,102,M,78,Many,Absent,Superficial Spreading,Axial,IIIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_103,,,,,,,Primary Melanoma_103,GSM1526122,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.36(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1395(follow-up time (months): 45,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526122/suppl/GSM1526122_0_Exiqon_14257952_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526122/suppl/GSM1526122_1_Exiqon_14257952_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526122,103,M,62,Many,Absent,Nodular,Axial,IIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_104,,,,,,,Primary Melanoma_104,GSM1526123,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.9(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 678(follow-up time (months): 22,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526123/suppl/GSM1526123_0_Exiqon_14257819_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526123/suppl/GSM1526123_1_Exiqon_14257819_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526123,104,M,82,Many,Present,Nodular,Axial,IIA,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_105,,,,,,,Primary Melanoma_105,GSM1526124,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2.5(time to 1st recurrence (days): 1200(time to 1st recurrence (months): 39(time to b-met (days): NA(follow-up time (days): 1295(follow-up time (months): 42,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526124/suppl/GSM1526124_0_Exiqon_14257821_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526124/suppl/GSM1526124_1_Exiqon_14257821_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526124,105,F,54,Few,Present,Acral Lentiginous,Extremity,IIIB,Y,LR,N,N,"Alive, With Melanoma",NA
primary_melanoma_106,,,,,,,Primary Melanoma_106,GSM1526125,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2(time to 1st recurrence (days): 233(time to 1st recurrence (months): 8(time to b-met (days): 957(follow-up time (days): 1201(follow-up time (months): 39,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526125/suppl/GSM1526125_0_Exiqon_14257925_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526125/suppl/GSM1526125_1_Exiqon_14257925_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526125,106,M,53,Many,Present,Nodular,Axial,IIA,Y,"RLN ,RS",N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_107,,,,,,,Primary Melanoma_107,GSM1526126,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 11(time to 1st recurrence (days): 148(time to 1st recurrence (months): 5(time to b-met (days): 148(follow-up time (days): 242(follow-up time (months): 7,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526126/suppl/GSM1526126_0_Exiqon_14257862_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526126/suppl/GSM1526126_1_Exiqon_14257862_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526126,107,F,79,Many,Present,Nodular,Axial,IIIB,Y,DV,Y,Y,"Died, With Melanoma",Melanoma
primary_melanoma_108,,,,,,,Primary Melanoma_108,GSM1526127,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4(time to 1st recurrence (days): 207(time to 1st recurrence (months): 7(time to b-met (days): NA(follow-up time (days): 374(follow-up time (months): 12,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526127/suppl/GSM1526127_0_Exiqon_14257818_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526127/suppl/GSM1526127_1_Exiqon_14257818_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526127,108,F,91,Many,Present,Nodular,Extremity,IIB,Y,"RLN , RS",N,N,"Died, With Melanoma",Melanoma
primary_melanoma_109,,,,,,,Primary Melanoma_109,GSM1526128,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.2(time to 1st recurrence (days): 561(time to 1st recurrence (months): 18(time to b-met (days): NA(follow-up time (days): 1676(follow-up time (months): 55,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526128/suppl/GSM1526128_0_Exiqon_14257895_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526128/suppl/GSM1526128_1_Exiqon_14257895_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526128,109,F,79,Moderate,Present,Nodular,Extremity,IIC,Y,LR,N,N,"Died, No Melanoma",NA
primary_melanoma_110,,,,,,,Primary Melanoma_110,GSM1526129,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 9.6(time to 1st recurrence (days): 49(time to 1st recurrence (months): 1(time to b-met (days): 152(follow-up time (days): 165(follow-up time (months): 5,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526129/suppl/GSM1526129_0_Exiqon_14257902_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526129/suppl/GSM1526129_1_Exiqon_14257902_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526129,110,F,34,Many,Present,Nodular,Axial,IIIC,Y,RLN,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_111,,,,,,,Primary Melanoma_111,GSM1526130,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 12(time to 1st recurrence (days): 273(time to 1st recurrence (months): 9(time to b-met (days): NA(follow-up time (days): 1570(follow-up time (months): 51,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526130/suppl/GSM1526130_0_Exiqon_14258005_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526130/suppl/GSM1526130_1_Exiqon_14258005_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526130,111,M,62,Many,Present,Nodular,Axial,IIC,Y,RLN,N,N,"Alive, No Melanoma",NA
primary_melanoma_112,,,,,,,Primary Melanoma_112,GSM1526131,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.62(time to 1st recurrence (days): 3965(time to 1st recurrence (months): 130(time to b-met (days): NA(follow-up time (days): 4924(follow-up time (months): 161,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526131/suppl/GSM1526131_0_Exiqon_14257864_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526131/suppl/GSM1526131_1_Exiqon_14257864_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526131,112,M,51,Many,Absent,Superficial Spreading,Axial,IB,Y,DV,N,N,"Alive, With Melanoma",NA
primary_melanoma_113,,,,,,,Primary Melanoma_113,GSM1526132,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 2(time to 1st recurrence (days): 1226(time to 1st recurrence (months): 41(time to b-met (days): NA(follow-up time (days): 1623(follow-up time (months): 53,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526132/suppl/GSM1526132_0_Exiqon_14257820_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526132/suppl/GSM1526132_1_Exiqon_14257820_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526132,113,M,44,Many,Absent,Superficial Spreading,Axial,IB,Y,DV,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_114,,,,,,,Primary Melanoma_114,GSM1526133,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 4.5(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 1469(follow-up time (months): 48,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526133/suppl/GSM1526133_0_Exiqon_14257853_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526133/suppl/GSM1526133_1_Exiqon_14257853_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526133,114,F,30,None,Absent,Desmoplastic,Axial,IIB,N,NA,N,N,"Alive, No Melanoma",NA
primary_melanoma_115,,,,,,,Primary Melanoma_115,GSM1526134,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 7(time to 1st recurrence (days): 364(time to 1st recurrence (months): 12(time to b-met (days): 544(follow-up time (days): 592(follow-up time (months): 19,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526134/suppl/GSM1526134_0_Exiqon_14257838_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526134/suppl/GSM1526134_1_Exiqon_14257838_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526134,115,M,72,Many,Present,Nodular,Axial,IIC,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_116,,,,,,,Primary Melanoma_116,GSM1526135,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.7(time to 1st recurrence (days): 455(time to 1st recurrence (months): 15(time to b-met (days): 455(follow-up time (days): 620(follow-up time (months): 20,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526135/suppl/GSM1526135_0_Exiqon_14257969_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526135/suppl/GSM1526135_1_Exiqon_14257969_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526135,116,M,76,Many,Present,Nodular,Extremity,IIB,Y,DV,Y,Y,"Died, With Melanoma",Melanoma
primary_melanoma_117,,,,,,,Primary Melanoma_117,GSM1526136,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 1.3(time to 1st recurrence (days): 352(time to 1st recurrence (months): 12(time to b-met (days): 433(follow-up time (days): 484(follow-up time (months): 15,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526136/suppl/GSM1526136_0_Exiqon_14257872_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526136/suppl/GSM1526136_1_Exiqon_14257872_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526136,117,M,57,Few,Absent,Superficial Spreading,Extremity,IIIA,Y,DV,N,Y,"Died, With Melanoma",Melanoma
primary_melanoma_118,,,,,,,Primary Melanoma_118,GSM1526137,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3(time to 1st recurrence (days): 1879(time to 1st recurrence (months): 61(time to b-met (days): NA(follow-up time (days): 2126(follow-up time (months): 69,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526137/suppl/GSM1526137_0_Exiqon_14257889_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526137/suppl/GSM1526137_1_Exiqon_14257889_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526137,118,M,72,Many,Present,Nodular,Axial,IIB,Y,DV,N,N,"Died, With Melanoma",Melanoma
primary_melanoma_119,,,,,,,Primary Melanoma_119,GSM1526138,Public on Feb 01 2015,Oct 15 2014,May 09 2015,RNA,2,Cutaneous primary melanoma,Homo sapiens,9606,primary tumor thickness (mm): 3.75(time to 1st recurrence (days): NA(time to 1st recurrence (months): NA(time to b-met (days): NA(follow-up time (days): 2870(follow-up time (months): 94,N/A,total RNA,Cy3 (Hy3),Common Reference,Homo sapiens,9606,material: Equal mixture of all samples,N/A,total RNA,Cy5 (Hy5),1_Exiqon is Cy3,GPL19296,"Eva,,Hernando-Monge",Eva.Hernando-Monge@nyumc.org,212-263-9054,NYU Langone Medical Center,550 1st Ave. Smilow 305,New York,NY,10016,USA,"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526138/suppl/GSM1526138_0_Exiqon_14257905_S01.txt.gz, ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1526nnn/GSM1526138/suppl/GSM1526138_1_Exiqon_14257905_S01.txt.gz","GSE62371, GSE62372",1314,,lowess normalized log 2 ratio (test/reference),GSM1526138,119,F,47,Many,Present,Superficial Spreading,Extremity,IIB,N,NA,N,N,"Alive, No Melanoma",NA
